FDA issued a Warning Letter to Namsa on 3/23/2018 for a previous inspection.
483 Namsa Sep 2021

483 Namsa Sep 2021

Nicole Victoria FDA$119.00 - Available Now

FDA investigators audited the Namsa - Minneapolis, MN, United States facility and issued inspectional observations (via FDA 483) on 21 Sep 2021.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 21 Sep 2021
  • Location: Minneapolis, United States
  • FEI: 3010138955
Add To Cart